Konica’s bio-injectable products include preparation devices for platelet-rich plasma and other blood cell therapies, administered using ultrasound guidance.
The single use kits prepare PRP and other cell-based therapies so clinicians can deliver efficiently in their practice.
The regenerative medicine market for sports medicine, orthopedics and pain management is projected to surpass $300 million in North America by 2025, according to a recent report by Grand View Research.
More articles on biologics:
Stryker ranks No. 8 in Fortune’s 100 best workplaces
Wuhan neurosurgeon, hospital director dies from coronavirus, death toll rises to 1,800+
Medtronic reports spine revenue up 3%, hurt by low BMP sales: 7 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
